Abnormal expression of Cyclin B1 and/or CDK1 has been reported in several types of tumors, such as epithelial ovarian cancer [23], non-small-cell lung cancer [24,25], tongue cancer [26], breast cancer [27], gastric cancer [28] and colorectal cancer [29]. This evidence concerns the gene CCNB1 and non-small cell lung carcinoma.